Publications

SELECTED WORK FROM OUR FELLOWS, COLLEAGUES, AND CORE FACULTY

July 21, 2025 - JAMA Network Open
Estimated Out-of-Pocket Costs for Patients With Common Cancers and Private Insurance. 

This study found that privately insured patients with newly diagnosed cancer, particularly those with more advanced disease, had substantial out-of-pocket costs.

September 24, 2024 - Medical Care
Hospital Presumptive Eligibility Emergency Medicaid Programs
An Opportunity for Continuous Insurance Coverage?

California patients who enroll in HPE often enroll in Medicaid coverage by 6 months, particularly among patients requiring surgical intervention, repeated health care visits, and ongoing access to care. Future opportunities include prospective evaluation of HPE recipients to understand the impact that Medicaid enrollment has on health care utilization and financial solvency.

August 20, 2024 - Annals of Internal Medicine
Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure: A Target Trial Emulation Study

Older adults starting dialysis when their eGFR fell below 12 mL/min/1.73 m2 who were not referred for transplant had modest gains in life expectancy and less time at home.

May 30, 2024 - JAMA Network Open
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.

Protocol-directed active surveillance is a safe management strategy for avoiding overtreatment and preventing undertreatment.

April 22, 2024 - JAMA Network Open
Antihypertensive Medication and Fracture Risk in Older Veterans Health Administration Nursing Home Residents.

Findings indicated that initiation of antihypertensive medication was associated with elevated risks of fractures and falls. These risks were numerically higher among residents with dementia, higher baseline blood pressures values, and no recent antihypertensive medication use.

April 1, 2024 - Surgery
Racial and Ethnic Disparities in Access to Total Neoadjuvant Therapy for Rectal Cancer.

No evidence of racial or ethnic disparities in survival among patients treated with total neoadjuvant therapy was found, suggesting that increasing access to high-quality cancer care may also improve health equity.

Date Title Publication Authors